Hope and Exploitation in Commercial Provision of Assisted Reproductive Technologies.
assisted reproductive technologies
bioethics
exploitation
hope
physician-patient relationship
Journal
The Hastings Center report
ISSN: 1552-146X
Titre abrégé: Hastings Cent Rep
Pays: United States
ID NLM: 0410447
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
medline:
16
11
2023
pubmed:
14
11
2023
entrez:
14
11
2023
Statut:
ppublish
Résumé
Innovation is a key driver of care provision in assisted reproductive technologies (ART). ART providers offer a range of add-on interventions, aiming to augment standard in vitro fertilization protocols and improve the chances of a live birth. Particularly in the context of commercial provision, an ever-increasing array of add-ons are marketed to ART patients, even when evidence to support them is equivocal. A defining feature of ART is hope-hope that a cycle will lead to a baby or that another test or intervention will make a difference. Yet such hope also leaves ART patients vulnerable in a variety of ways. This article argues that previous attempts to safeguard ART patients have neglected how the use of add-ons in commercial ART can exploit patients' hopes. Commercial providers of ART should provide add-ons only free of charge, under a suitable research protocol.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
30-41Subventions
Organisme : National Health and Medical Research Council of Australia
ID : APP1181401
Informations de copyright
© 2023 The Hastings Center.
Références
Reprod Biomed Online. 2020 Jan;40(1):2-5
pubmed: 31924494
Hum Reprod. 2017 Mar 1;32(3):485-491
pubmed: 28158511
Hum Reprod. 2021 Jun 18;36(7):1854-1861
pubmed: 33942073
Hastings Cent Rep. 2023 Sep;53(5):30-41
pubmed: 37963135
J Med Ethics. 2019 May;45(5):346-350
pubmed: 30745435
Reprod Biomed Online. 2019 Jun;38(6):853-856
pubmed: 31023611
BMJ. 2004 Jun 19;328(7454):1494-6
pubmed: 15205296
Hum Reprod Open. 2020 Dec 23;2020(4):hoaa059
pubmed: 33392395
Hum Fertil (Camb). 2013 Mar;16(1):22-5
pubmed: 23530725
BMJ Open. 2016 Nov 27;6(11):e013940
pubmed: 27890866
Int J Behav Med. 2022 Apr;29(2):209-219
pubmed: 34008158
Hastings Cent Rep. 2008 Sep-Oct;38(5):49-55
pubmed: 18947141
Fertil Steril. 2019 Dec;112(6):973-977
pubmed: 31703942
Bioethics. 2015 Sep;29(7):478-87
pubmed: 25425540
BMJ. 2016 Dec 1;355:i6434
pubmed: 27908888